Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RC48-ADC and PRaG 3.0 Regimen in HER2-Positive Advanced Solid Tumors
NCT05115500Phase 2Unknown
- Sponsor
- The Second Affiliated Hospital of Soochow University
- Start
- Nov 2021
- Primary completion
- Oct 2024
- Countries
- 1
01
Overview
Phase 2, open-label trial of disitamab vedotin in solid tumor, sponsored by The Second Affiliated Hospital of Soochow University. Status: unknown.
02
Drugs
disitamab vedotin
03
Conditions
solid tumor
Beyond the preview
Go deeper on NCT05115500.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05115500.